PEPG
Price
$1.22
Change
+$0.01 (+0.83%)
Updated
Jul 3 closing price
Capitalization
39.92M
34 days until earnings call
XNCR
Price
$8.42
Change
+$0.12 (+1.45%)
Updated
Jul 3 closing price
Capitalization
599.26M
26 days until earnings call
Interact to see
Advertisement

PEPG vs XNCR

Header iconPEPG vs XNCR Comparison
Open Charts PEPG vs XNCRBanner chart's image
PepGen
Price$1.22
Change+$0.01 (+0.83%)
Volume$152.26K
Capitalization39.92M
Xencor
Price$8.42
Change+$0.12 (+1.45%)
Volume$306.91K
Capitalization599.26M
PEPG vs XNCR Comparison Chart in %
Loading...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PEPG vs. XNCR commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEPG is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (PEPG: $1.22 vs. XNCR: $8.42)
Brand notoriety: PEPG and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PEPG: 65% vs. XNCR: 33%
Market capitalization -- PEPG: $39.92M vs. XNCR: $599.26M
PEPG [@Biotechnology] is valued at $39.92M. XNCR’s [@Biotechnology] market capitalization is $599.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PEPG’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • PEPG’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both PEPG and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PEPG’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • PEPG’s TA Score: 4 bullish, 6 bearish.
  • XNCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PEPG is a better buy in the short-term than XNCR.

Price Growth

PEPG (@Biotechnology) experienced а -4.69% price change this week, while XNCR (@Biotechnology) price change was +0.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

PEPG is expected to report earnings on Aug 07, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($599M) has a higher market cap than PEPG($39.9M). XNCR YTD gains are higher at: -63.359 vs. PEPG (-67.810). PEPG has higher annual earnings (EBITDA): -102.93M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. PEPG (97.8M). PEPG has less debt than XNCR: PEPG (18.3M) vs XNCR (67.8M). XNCR has higher revenues than PEPG: XNCR (127M) vs PEPG (0).
PEPGXNCRPEPG / XNCR
Capitalization39.9M599M7%
EBITDA-102.93M-161.68M64%
Gain YTD-67.810-63.359107%
P/E RatioN/AN/A-
Revenue0127M-
Total Cash97.8M470M21%
Total Debt18.3M67.8M27%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PEPGXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DAINX20.32N/A
N/A
Dunham International Stock A
GEQZX61.76N/A
N/A
GuideStone Funds Equity Index Investor
TEGYX43.92N/A
N/A
Touchstone Mid Cap Growth Y
FSRKX8.82N/A
N/A
Fidelity Strategic Real Return K6
RBVAX15.04N/A
N/A
RBC Small Cap Value A

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with SLDB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
+0.83%
SLDB - PEPG
38%
Loosely correlated
+3.29%
MGNX - PEPG
36%
Loosely correlated
+5.80%
XNCR - PEPG
32%
Poorly correlated
+1.45%
FENC - PEPG
32%
Poorly correlated
+3.04%
ERAS - PEPG
30%
Poorly correlated
-0.69%
More